CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-03 | Williams Patrick F. Director | Grant or award · Stock Option | +10,490 | 10,490 | ||
| 2022-11-03 | Rosa David A Director | Returned to the company · Stock Option | −10,490 | 0 | ||
| 2022-11-03 | Rosa David A Director | Grant or award · Stock Option | +10,490 | 10,490 | ||
| 2022-11-03 | ALSTODT LANCE President, CEO, COB | Returned to the company · Stock Option | −293,479 | 0 | ||
| 2022-11-03 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +293,479 | 293,479 | ||
| 2022-11-03 | ALSTODT LANCE President, CEO, COB | Returned to the company · Stock Option | −42,059 | 0 | ||
| 2022-11-03 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +42,059 | 42,059 | ||
| 2022-10-12 | Silva Francisco VP of Research and Development | Purchase | +725 | $3.39 | $2K | 165,103 |
| 2022-10-11 | Silva Francisco VP of Research and Development | Purchase | +806 | $3.69 | $3K | 164,378 |
| 2022-09-23 | Broadrick Dale 10% owner | Purchase | +300 | $2.83 | $849 | 298,873 |
| 2022-09-22 | ALSTODT LANCE President, CEO, COB | Purchase | +100 | $2.99 | $299 | 182,821 |
| 2022-09-22 | ALSTODT LANCE President, CEO, COB | Purchase | +100 | $2.85 | $285 | 182,921 |
| 2022-08-29 | Silva Francisco VP of Research and Development | Purchase | +2,816 | $3.21 | $9K | 163,572 |
| 2022-08-29 | Silva Francisco VP of Research and Development | Purchase | +307 | $3.32 | $1K | 12,136 |
| 2022-08-26 | Silva Francisco VP of Research and Development | Sale | −3,958 | $3.39 | $13K | 158,156 |
| 2022-08-26 | Silva Francisco VP of Research and Development | Purchase | +2,600 | $3.35 | $9K | 160,756 |
| 2022-07-13 | Broadrick Dale 10% owner | Purchase | +200 | $3.00 | $600 | 298,573 |
| 2022-07-12 | Broadrick Dale 10% owner | Purchase | +900 | $2.97 | $3K | 298,373 |
| 2022-07-12 | ALSTODT LANCE President, CEO, COB | Purchase | +700 | $2.95 | $2K | 182,721 |
| 2022-07-06 | Broadrick Dale 10% owner | Purchase | +100 | $3.38 | $338 | 297,473 |
Page 5 of 30 · 598 trades